A neurostimulation system is disclosed for providing treatment to a patient during a therapy session. The neurostimulation system includes a neurostimulator for transmitting magnetic or electrical signals based upon a treatment program. A programmer is connected to the neurostimulator to set a treatment session parameter value to calculate a therapy compliance value. A compliance module is connected to the neurostimulator and the programmer to calculate and store a therapy compliance value. A control module is connected to the compliance module, the programmer and the neurostimulator and determines whether the therapy compliance value is within a range of the treatment program. The neurostimulator transmits electrical or magnetic signals to the patient in a treatment session only if the therapy compliance value meets a compliance criteria.

The present disclosure provides a system for delivery of therapeutic energy. The system includes an energy unit configured to convert the acoustic energy signals transmitted to therapeutic ultrasound directed to fragment tumors and carcinogenic tissue in the body. The system also includes an energy unit configured to convert the acoustic energy signal transmitted from the energy unit to ultrasonic energy to image and monitor the treatment site with ultrasound. The system also includes a control unit including a computer for data storage and display.

Devices, systems and methods are disclosed for treating or preventing an autism spectrum disorder, a pervasive developmental disorder, or a disorder of psychological development. The methods comprise transmitting impulses of energy non-invasively to selected nerve fibers, particularly those in a vagus nerve. The nerve stimulation may be used as a behavior conditioning tool, by producing euphoria in an autistic individual. Vagus nerve stimulation is also used to modulate circulating serotonin levels in a pregnant woman so as to reduce the risk of having an autistic child; modulate the levels of growth factors within a child; promote balance of neuronal excitation/inhibition; modulate the activity of abnormal resting state neuronal networks; increase respiratory sinus arrhythmia; and avert episodes of motor stereotypies with the aid of forecasting methods.

A magnetic stimulation device having planar coil structure is disclosed. It contains a power supply module, a current control module, a plurality of planar coil modules and a plurality of electrical connection modules. In the planar coil module of the present invention, the coil structure has a flat and thin design and can be modularized. Compared with the existing magnetic stimulation devices, the overall structure of the present invention is light, thin, short, convenient to carry and use, and can be installed on clothing or built in a mobile device to provide a convenient magnetic stimulation treatment.

A magnetic stimulation device having planar coil structure is disclosed. It contains a power supply module, a current control module, a plurality of planar coil modules and a plurality of electrical connection modules. In the planar coil module of the present invention, the coil structure has a flat and thin design and can be modularized. Compared with the existing magnetic stimulation devices, the overall structure of the present invention is light, thin, short, convenient to carry and use, and can be installed on clothing or built in a mobile device to provide a convenient magnetic stimulation treatment.

An apparatus and method collect and deactivate pathogens (for example, coronaviruses) within a magnetic particle in order to reduce the number of active pathogens in a body.

A solenoid device for generating or detecting electrical or magnetic fields includes at least two solenoids combined into a solenoid structure. A two level solenoid structure is formed by helically wrapping a long and bendable primary solenoid around a secondary core to create a secondary solenoid which includes the primary solenoid as a part. If the secondary solenoid is bendable and long enough, it can be helically wrapped around a tertiary core to form a tertiary solenoid which contains the primary solenoid and the secondary solenoid as parts. The upper level solenoid will generally contain a hollow core into which items or bodies to be treated with electrical or magnetic fields can be inserted for treatment. Further, items having inherent magnetic or electrical fields or properties can be inserted into the hollow core so the inherent fields can be detected.

A neuromodulation system includes a conductive element, a magnetic field generator, a power module and a computer processor. The conductive element located internal a patient's body. At least a portion of the conductive element is positioned adjacent to a target tissue. The magnetic field generator is positioned external to the patient's body. The magnetic field generator generates a time varying magnetic field for inducing stimulation of the target tissue in combination with the conductive element to produce stimulation that is larger than that which would occur in the absence of the conductive element. The power module supplies power to the magnetic field generator. The computer processor controls the time varying magnetic field provided by the magnetic field generator according to at least one set of stimulation parameters.

A neuromodulation system includes a conductive element, a magnetic field generator, a power module and a computer processor. The conductive element located internal a patient's body. At least a portion of the conductive element is positioned adjacent to a target tissue. The magnetic field generator is positioned external to the patient's body. The magnetic field generator generates a time varying magnetic field for inducing stimulation of the target tissue in combination with the conductive element to produce stimulation that is larger than that which would occur in the absence of the conductive element. The power module supplies power to the magnetic field generator. The computer processor controls the time varying magnetic field provided by the magnetic field generator according to at least one set of stimulation parameters.

The technology disclosed herein relates to a transcutaneous irradiation device having a top portion and a bottom portion. The top portion may include one or more transcutaneous irradiation modules configured to be arranged on a head of a user, the top transcutaneous irradiation modules including a top pulsed laser source. The bottom portion may include one or more transcutaneous irradiation modules configured to be arranged on an abdomen of the user, the top transcutaneous irradiation modules including a bottom pulsed laser source. A modulation frequency may be applied to the top and bottom irradiation modules such that the top and bottom pulse laser sources are subjected to a double pulse.